Stock Chart
TERN
Type: SELL wallstreet
Strike: $55
Premium: $13.75
Expiry: Jan 15, 2027
Target: $58
Score: -77
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About TERN - Terns Pharmaceuticals, Inc. Common Stock
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
Key Statistics
More TERN Analysis
This TERN stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track TERN's price movements with trendlines, gamma walls, and key support/resistance levels.